Semaglutide for Alzheimer’s: What the EVOKE Trials Taught Us What happens when a promising therapy falls short? Medscape spoke with Jeffrey Cummings, MD, who led the EVOKE trials of the GLP-1 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results